NEW YORK (GenomeWeb News) – Privately held firms Gentag and MacroArray Technologies said today that they will collaborate on developing a wireless immunoassay for prostate cancer.
 
The new test would combine Gentag’s cell-phone sensor technology with MacroArray’s proteomics discovery technology to create a disposable, wireless diagnostic test.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.